InnovAge Agrees to Pay $36 Million Settlement
The Denver-based senior care provider settles allegations of federal and state violations tied to specialist care under Medicare and Medicaid.
Updated on Nov. 17, 2026 in Healthcare

Live Poll
Do you trust private companies running publicly funded senior care to deliver timely care?
InnovAge Holding agreed to pay $36 million to resolve allegations of federal and state law violations. The settlement is not a determination of liability, and the company did not immediately respond to a request for comment.
Why it matters
The allegations concern whether a provider serving seniors under a dual Medicare-Medicaid program maintained adequate specialist networks and scheduled timely care. The case shows how federal and state regulators enforce program requirements through the False Claims Act.
The $36 million settlement comprises roughly $25.7 million paid to the U.S. and $10.3 million split among four states, covering alleged conduct spanning 2016 to 2022. Whether the allegations will be contested or the amounts will change was not addressed in the source material.
The players
InnovAge Holding
InnovAge is a Denver-headquartered organization that provides healthcare services to seniors through centers funded by Medicare and Medicaid.
The details
The Justice Department alleges InnovAge did not keep adequate specialist provider networks and failed to timely schedule appointments in oncology, cardiology, surgery and neurology, violating the federal False Claims Act and state laws. InnovAge receives Medicare and Medicaid funding to serve seniors at centers across several states.
Timeline
2016 to 2022: Period of alleged failures to maintain specialist networks and schedule timely care.
November 17, 2026: Settlement publicly reported.
Healthcare Landscape
The settlement follows the pattern of False Claims Act enforcement against Medicare Advantage and dual-eligible program providers, where regulators pursue compliance with network adequacy and care-timeliness requirements. It places InnovAge within a continuing federal focus on how publicly funded senior care is delivered.
Seniors enrolled in dual Medicare-Medicaid programs depend on timely access to specialists in oncology, cardiology, surgery and neurology. The allegations highlight that delayed referrals and thin provider networks can directly affect how quickly older patients receive treatment.
The takeaway
Patients in government-funded senior care programs can ask their providers how specialist referrals are scheduled and what network options exist for their needs. Verifying that a specialist is in-network before an appointment helps avoid delays in care.
Further reading
Explore more on Healthcare policy and program enforcement across the United States.
Live Poll
Do you trust private companies running publicly funded senior care to deliver timely care?






